product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Goat anti WNT-3
catalog :
AHP2268
quantity :
0.1 mg
price :
439 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human
application :
western blot, ELISA, immunocytochemistry
more info or order :
image
image 1 :
Bio-Rad AHP2268 image 1
Western blotting analysis of HEK293 cell line lysate (35ug protein in RIPA buffer) probed with Goat anti Human WNT-3 antibody ( AHP2268 ) at 1.0ugml -1 . Primary incubation was 1 hour. Signal was detected by chemiluminescence
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
ProductCode :
AHP2268
Description :
Goat anti WNT-3
Specificity :
WNT-3
TargetSpecies :
Human
Host :
Goat
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB,P,E,IF
ApplicationTypes :
Western Blotting,Immunohistology - Paraffin,ELISA,Immunofluorescence
Cross Reactivities :
Mouse,Dog,Rat
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0005886,GO:0000902,GO:0001707,GO:0004871,GO:0007223,GO:0005109,GO:0005110,GO:0005578,GO:0005615,GO:0005624,GO:0005769,GO:0005770,GO:0009880,GO:0008284,GO:0009950,GO:0010552,GO:0010553,GO:0030182,GO:0030917,GO:0035115,GO:0035116,GO:0042472,GO:0044338,GO:0044339,GO:0045121,GO:0045599,GO:0060064,GO:0060174,GO:0060323,GO:0061180,GO:0071300,GO:0071425
GOTerms :
plasma membrane,cell morphogenesis,mesoderm formation,signal transducer activity,Wnt receptor signaling pathway, calcium modulating pathway,frizzled binding,frizzled-2 binding,proteinaceous extracellular matrix,extracellular space,membrane fraction,early endosome,late endosome,embryonic pattern specification,positive regulation of cell proliferation,dorsal/ventral axis specification,positive regulation of gene-specific transcription from RNA polymerase II promoter,negative regulation of gene-specific transcription from RNA polymerase II promoter,neuron differentiation,midbrain-hindbrain boundary development,embryonic forelimb morphogenesis,embryonic hindlimb morphogenesis,inner ear morphogenesis,canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation,canonical Wnt receptor signaling pathway involved in osteoblast differentiation,membrane raft,negative regulation of fat cell differentiation,Spemann organizer formation at the anterior end of the primitive streak,limb bud formation,head morphogenesis,mammary gland epithelium development,cellular response to retinoic acid,hemopoietic stem cell proliferation
Uniprot Accessions :
P56703
Gene :
WNT3
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7473
Published Synonyms :
INT4
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
313
PriceEUR :
439
PriceUSD :
439 USD
PriceCHF :
478
PriceSEK :
4785
PriceNOK :
4809
PriceDKK :
3273
NotForSaleInCountries :
CA
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.